Topical hyaluronic acid vs. standard of care for the prevention of radiation dermatitis after adjuvant radiotherapy for breast cancer: Single-blind randomized phase III clinical trial

International Journal of Radiation Oncology Biology Physics

Volumn 83, Issue 4, 2012, Pages 1089-1094

  Pinnix, Chelsea ^a   Perkins, George H ^a   Strom, Eric A ^a   Tereffe, Welela ^a   Woodward, Wendy ^a   Oh, Julia L ^a   Arriaga, Lisa ^a   Munsell, Mark F ^a   Kelly, Patrick ^a   Hoffman, Karen E ^a   Smith, Benjamin D ^a   Buchholz, Thomas A ^a   Yu, T Kuan ^b  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^b Houston Precision Cancer Center   (United States)

Author keywords

Breast cancer; Hyaluronic acid; Petrolatum gel; Radiation dermatitis

Indexed keywords

ADJUVANT RADIOTHERAPY; BREAST CANCER; CLINICAL TRIAL; COMMON TERMINOLOGY CRITERIA; HYALURONIC ACIDS; PROSPECTIVE RANDOMIZED TRIAL; SAFETY MONITORING;

DISEASES; EMULSIFICATION; ORGANIC ACIDS; PARAFFIN WAXES;

RADIOTHERAPY;

HYALURONIC ACID; PETROLATUM; RADIAPLEX; UNCLASSIFIED DRUG; XIPAMIDE;

ADULT; AGED; ARTICLE; BREAST CANCER; CANCER RADIOTHERAPY; COMPARATIVE EFFECTIVENESS; CONTROLLED STUDY; DISEASE EXACERBATION; DRUG EFFICACY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; PARTIAL MASTECTOMY; PHASE 3 CLINICAL TRIAL; PRIORITY JOURNAL; RADIATION DERMATITIS; RADIATION DOSE; RANDOMIZED CONTROLLED TRIAL; SINGLE BLIND PROCEDURE;

ADMINISTRATION, TOPICAL; ADULT; AGED; BREAST; BREAST NEOPLASMS; EARLY TERMINATION OF CLINICAL TRIALS; EMOLLIENTS; FEMALE; HUMANS; HYALURONIC ACID; MASTECTOMY, SEGMENTAL; MIDDLE AGED; ORGAN SIZE; PETROLATUM; RADIATION-PROTECTIVE AGENTS; RADIODERMATITIS; RADIOTHERAPY, ADJUVANT; SINGLE-BLIND METHOD; TREATMENT FAILURE;

EID: 84862649957     PISSN: 03603016     EISSN: 1879355X     Source Type: Journal    
DOI: 10.1016/j.ijrobp.2011.09.021     Document Type: Article

References (13)

1. Fisher B, Anderson S, Bryant J, et al. Twenty-year follow-up of a randomized trial comparing total mastectomy, lumpectomy, and lumpectomy plus irradiation for the treatment of invasive breast cancer. N Engl J Med 2002;347:1233-1241.
2. Fisher J, Scott C, Stevens R, et al. Randomized phase III study comparing best supportive care to biafine as a prophylactic agent for radiation-induced skin toxicity for women undergoing breast irradiation: Radiation Therapy Oncology Group (RTOG) 97-13. Int J Radiat Oncol Biol Phys 2000;48:1307-1310.
3. Elliott EA, Wright JR, Swann RS, et al. Phase III Trial of an emulsion containing trolamine for the prevention of radiation dermatitis in patients with advanced squamous cell carcinoma of the head and neck: Results of Radiation Therapy Oncology Group Trial 99-13. J Clin Oncol 2006;24:2092-2097.
4. Gracy R LK, Phelps J. RadiaPlexRx gel protects cultured skin cells from oxidative free radical damage induced by hydrogen peroxide and by irradiation: A pilot study. Chicago: 2005. Radiological Society of North America. Vol SSA20-08. P.300.
5. Liguori V, Guillemin C, Pesce GF, et al. Double-blind, randomized clinical study comparing hyaluronic acid cream to placebo in patients treated with radiotherapy. Radiother Oncol 1997;42: 155-161.
6. Borghero YO, Salehpour M, McNeese MD, et al. Multileaf field-in-field forward-planned intensity-modulated dose compensation for whole-breast irradiation is associated with reduced contralateral breast dose: A phantom model comparison. Radiother Oncol 2007;82: 324-328.
7. Trotti A, Colevas AD, Setser A, et al. CTCAE v3.0: Development of a comprehensive grading system for the adverse effects of cancer treatment. Semin Radiat Oncol 2003;13:176-181.
8. Croce MA, Dyne K, Boraldi F, et al. Hyaluronan affects protein and collagen synthesis by in vitro human skin fibroblasts. Tissue Cell 2001; 33:326-331.
9. Ellis IR, Schor SL. Differential effects of TGF-beta1 on hyaluronan synthesis by fetal and adult skin fibroblasts: Implications for cell migration and wound healing. Exp Cell Res 1996;228:326-333.
10. Kirova YM. Hyaluronic acid versus simple emollient for managment of radio-induced toxicity: Results of open label phase III trial. San Diego: Association for Society of Radiation Oncology. Vol Abstract # 2971. 2010.
11. Fernando IN, Ford HT, Powles TJ, et al. Factors affecting acute skin toxicity in patients having breast irradiation after conservative surgery: A prospective study of treatment practice at the Royal Marsden Hospital. Clin Oncol 1996;8:226-233.
12. Pignol JP, Olivotto I, Rakovitch E, et al. A multicenter randomized trial of breast intensity-modulated radiation therapy to reduce acute radiation dermatitis. J Clin Oncol 2008;26:2085-2092.
13. Murthy KK, Sivakumar SS, Davis CA, et al. Optimization of dose distribution with multi-leaf collimator using field-in-field technique for parallel opposing tangential beams of breast cancers. J Med Phys 2008;33:60-63.